Related Experiment Videos
Clopidogrel for smokers and aspirin for nonsmokers?: not so fast
1Oregon State University/Oregon Health and Science University College of Pharmacy, Portland, Oregon, USA.
Clinical Pharmacology and Therapeutics
|May 21, 2014
Abstract:
New data solidify a "smoker's paradox" for clopidogrel, with current smokers appearing to respond better than nonsmokers. However, the clinical implications of this finding are unclear. This Commentary discusses the new data and puts it into clinical context.